BioDlink International Company Limited (HKG:1875)
4.020
0.00 (0.00%)
Aug 21, 2026, 4:08 PM HKT
HKG:1875 Revenue
BioDlink International Company had revenue of 258.51M CNY in the half year ending December 31, 2025, a decrease of -42.88%. This brings the company's revenue in the last twelve months to 504.52M, down -52.71% year-over-year. In the year 2025, BioDlink International Company had annual revenue of 747.65M, down -31.93%.
Revenue (ttm)
504.52M CNY
Revenue Growth
-52.71%
P/S Ratio
3.73
Revenue / Employee
823.03K CNY
Employees
613
Market Cap
3.11B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 747.65M | -350.68M | -31.93% |
| Dec 31, 2024 | 1.10B | 317.70M | 40.70% |
| Dec 31, 2023 | 780.63M | 338.45M | 76.54% |
| Dec 31, 2022 | 442.18M | 365.85M | 479.34% |
| Dec 31, 2021 | 76.33M | 53.83M | 239.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Frontage Holdings | 2.00B |
| Viva Biotech Holdings | 1.92B |
| Shandong Boan Biotechnology | 873.36M |
| Antengene Corporation | 652.54M |
| Medtide | 634.40M |
| Mirxes Holding Company | 166.32M |
| HJ Science | 14.54M |
| Clover Biopharmaceuticals | 3.90M |